Magnus Moliteus

All filings by Magnus Moliteus on record concern Dusa Pharmaceuticals Inc. The record holds 8 filings, for trades running from 14 May 2007 to 20 December 2012.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The record was last updated on 20 December 2012 with a transaction (€282k) in Dusa Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.